Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Hcv-Hepatitis'

Hcv-Hepatitis published presentations and documents on DocSlides.

HCV Assays: Impact on HCV Studies
HCV Assays: Impact on HCV Studies
by blanko
& . Update on HCV . blood bank protocol. . Ov...
HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC
HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC
by jovita
Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...
HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*
HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*
by jesse588
Mandatory criteria: . Probability based sampling. ...
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...
HIV & HCV through the Medicine Wheel
HIV & HCV through the Medicine Wheel
by winnie
Our Services. Emotional:. Reactions. Feelings abou...
NITCAR HCV Audit Chloe Eaton, Suzie English, Ben Warne
NITCAR HCV Audit Chloe Eaton, Suzie English, Ben Warne
by candy
Supervising Consultant: Dr K. . Rolfe. Update: Mar...
Sofosbuvir + Ribavirin in HCV Recurrence
Sofosbuvir + Ribavirin in HCV Recurrence
by williams
Following Liver Transplantation. Phase 2. Charlton...
EASL 2019 HCV Conference Update
EASL 2019 HCV Conference Update
by sophia
April 10. –14. , 2019. Vienna, Austria. Disclaim...
Abbott RealTime HCV Genotype II PMA CONFIDENTIAL
Abbott RealTime HCV Genotype II PMA CONFIDENTIAL
by desha
mHCV Genotype II Key to symbols used Global Tra...
Aptima HCV RNA Qualitative Assay
Aptima HCV RNA Qualitative Assay
by delilah
Aptima HCV RNA Qualitative Assay1 500237 Rev. 003 ...
Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA
Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA
by WannabeRockstar
seroconversion. and genetically linked HCV infect...
Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Thro
Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Thro
by SoulfulDreamer
(Resolution 13). Ad Hoc Disease Transmission Advis...
Economic Impact of Eliminating HCV
Economic Impact of Eliminating HCV
by InLoveWithLife
H. . Razavi. April 13, 2016. HCV Economic impact m...
HIV-HCV Coinfection in the era of effective antiviral therapy
HIV-HCV Coinfection in the era of effective antiviral therapy
by mia
Mark Sulkowski, . MD. Professor of Medicine. Medic...
Treatment of Chronic HCV
Treatment of Chronic HCV
by lam
with Direct-Acting Antivirals (DAAs). www.hcvguide...
Use of HCV DAAs with HIV Regimens
Use of HCV DAAs with HIV Regimens
by robaut
Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....
Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence
Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence
by briana-ranney
Sofosbuvir + Ribavirin to Prevent Post-Transplan...
OraQuick HCV Rapid Test
OraQuick HCV Rapid Test
by sherrill-nordquist
How to Run the . Test . Overview. Background Pres...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
by danika-pritchard
NIAID Retreatment. Phase . 2a . Treatment. . Exp...
INTEGRATING HIV AND HCV TESTING
INTEGRATING HIV AND HCV TESTING
by cheryl-pisano
30. 40. 50. 60. 70. 80. 90. 1. 00. 0 . 1. 0. . 2...
Is it possible? HCV Elimination
Is it possible? HCV Elimination
by yoshiko-marsland
Objectives. Define elimination as it relates to i...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
Prevention strategies for HIV/HCV co infection
Prevention strategies for HIV/HCV co infection
by giovanna-bartolotta
Isabelle Andrieux-Meyer, MD. Médecins Sans Front...
Effects of HIV/HCV coinfection on Bone Mineral Density and Structure
Effects of HIV/HCV coinfection on Bone Mineral Density and Structure
by min-jolicoeur
Amber Wheeler, MD. WIHS Scientific Meeting. June ...
Care of the Treatment-naive Patient With HCV/HIV Coinfection
Care of the Treatment-naive Patient With HCV/HIV Coinfection
by cheryl-pisano
. Case. 47-Year-Old . Man With Asymptomatic HIV ...
Simplified HCV Therapy in 2018
Simplified HCV Therapy in 2018
by phoebe-click
This program is s. upported. by educational gran...
O nline census of drug consumption rooms as a setting to address HCV:
O nline census of drug consumption rooms as a setting to address HCV:
by phoebe-click
 . current practice and future capacity.. Vendul...
An Overview of HIV and HCV in Adolescents and Young Adults
An Overview of HIV and HCV in Adolescents and Young Adults
by pamella-moone
Cathryn. L. Samples, MD, MPH, AAHIVS. Director, ...
Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6
Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6
by celsa-spraggs
C-EDGE Treatment Naïve (TN). Phase 3. . Treatme...
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
by pasty-toler
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
Housing Choice Voucher Program
Housing Choice Voucher Program
by phoebe-click
LANDLORD BRIEFING. 2015. KHRA & HCV ~ Overvie...
Access to antiviral drugs for treating HCV for HIV-positive
Access to antiviral drugs for treating HCV for HIV-positive
by yoshiko-marsland
AIDS 2016 | 18-22 July 2016 | Durban, South A...
Sofosbuvir in HCV-
Sofosbuvir in HCV-
by mitsue-stanley
HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...
Sofosbuvir + Ribavirin in HCV Genotype 1
Sofosbuvir + Ribavirin in HCV Genotype 1
by pamella-moone
NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...
Role of harm reduction in HCV prevention in France: from r
Role of harm reduction in HCV prevention in France: from r
by tatiana-dople
Bruno Spire & Patrizia Carrieri. How to reduc...
Treatment with the second-generation HCV protease inhibitor
Treatment with the second-generation HCV protease inhibitor
by conchita-marotz
Results from SILEN-C1 in HCV genotype-1 treatment...
Management of HCV in Co-Infected Patients
Management of HCV in Co-Infected Patients
by danika-pritchard
Marie-Louise Vachon, MD, . MSc. Division of . Inf...
Future HCV Treatment Paradigms
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
Update on the HCV Antiviral Pipeline
Update on the HCV Antiviral Pipeline
by natalia-silvester
Todd S. Wills, MD. SPNS HCV Treatment Expansion I...